Related references
Note: Only part of the references are listed.Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
Michal Zabczyk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
Isaac See et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)
Johannes Thaler et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine
Rolf Ankerlund Blauenfeldt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
Marie Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
Kate-Lynn Muir et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Nina H. Schultz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia
Douglas B. Cines et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Andreas Greinacher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer
Jerald Sadoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination
Jonathan Douxfils et al.
THROMBOSIS RESEARCH (2021)
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
Anton Pottegard et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis
Tilmann Graf et al.
JOURNAL OF NEUROLOGY (2021)
Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
Talal Al-Mayhani et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance
Senna Staessens et al.
HAEMATOLOGICA (2020)
Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation
Ian Johnston et al.
BLOOD (2020)
Insights from thrombi retrieved in stroke due to large vessel occlusion
Marco Bacigaluppi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review
Theodore E. Warkentin
EXPERT REVIEW OF HEMATOLOGY (2019)
Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes
Maurizio Paciaroni et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Neutrophil extracellular traps in immunity and disease
Venizelos Papayannopoulos
NATURE REVIEWS IMMUNOLOGY (2018)
Autoimmune heparin-induced thrombocytopenia
A. Greinacher et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
New platelet functional method for identification of pathogenic antibodies in HIT patients
M. L. Guarino et al.
PLATELETS (2017)
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcγRIIA
MP Reilly et al.
BLOOD (2001)